Sun BioPharma Net income (FY, 2018)-5.9 M
Sun BioPharma EBIT (FY, 2018)-3.9 M
Sun BioPharma Cash, 31-Dec-20181.4 M

Sun BioPharma Income Statement

Sun BioPharma Balance Sheet

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

58.8k925.0k438.0k152.0k1.4m

Accounts Receivable

14.8k

Current Assets

432.8k1.7m877.0k767.0k1.8m

PP&E

19.2k

Total Assets

532.3k1.8m877.0k767.0k1.9m

Accounts Payable

4.0k585.0k1.2m1.2m1.1m

Short-term debt

1.5m

Current Liabilities

663.7k1.4m5.5m4.2m1.6m

Long-term debt

300.0k2.7m

Non-Current Liabilities

3.1m286.0k

Total Debt

300.0k2.7m1.5m

Total Liabilities

670.2k

Additional Paid-in Capital

13.5m10.9m14.0m25.6m35.0m

Retained Earnings

(13.9m)(13.7m)(18.8m)(29.2m)(35.1m)

Total Equity

(137.9k)(4.6m)(3.7m)268.0k

Debt to Equity Ratio

-0.4 x

Debt to Assets Ratio

2 x

Financial Leverage

-3.9 x-0.2 x-0.2 x7.1 x

Sun BioPharma Cash Flow

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(212.0k)(4.9m)(5.1m)(10.4m)(5.9m)

Depreciation and Amortization

8.8k

Accounts Receivable

60.7k

Accounts Payable

(24.1k)681.0k726.0k(319.0k)360.0k

Cash From Operating Activities

(3.9m)(2.4m)(3.4m)(2.4m)

Purchases of PP&E

(5.1k)

Cash From Investing Activities

(5.1k)

Cash From Financing Activities

(11.6k)2.7m1.9m3.1m3.6m

Interest Paid

1.4k

Income Taxes Paid

220.0

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018Q2, 2018

Net Income

(191.9k)(110.6k)(167.9k)(263.6k)(4.2m)(824.0k)(1.8m)(2.9m)(1.8m)(4.2m)

Depreciation and Amortization

6.1k2.7k5.0k7.3k

Accounts Receivable

55.8k(6.5k)(880.0)(2.6k)

Accounts Payable

(14.2k)8.7k8.6k(629.0)208.0k493.0k500.0k787.0k111.0k(67.0k)

Cash From Operating Activities

(3.0m)(542.0k)(631.0k)(1.6m)(588.0k)(1.6m)

Purchases of PP&E

(3.5k)(3.4k)

Cash From Investing Activities

136.6k(1.8k)35.6k121.3k500.0k

Cash From Financing Activities

(6.0k)(2.2k)(4.1k)(2.8k)2.7m1.6m1.9m1.6m2.3m

Sun BioPharma Ratios

USDY, 2018

Financial Leverage

7.1 x